Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 39 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 8961975

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  2. US 8957192

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  3. US 8957188

    Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  4. US 8951793

    Method of making an isolated population of FOXP3+ regulatory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  5. US 8951527

    Radioprotectants targeting thrombospondin-1 and CD47

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  6. US 8946398

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  7. US 8946382

    Apelin peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  8. US 8946291

    Compositions and methods for treating pigmentary conditions and melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  9. US 8946243

    Compounds and methods for the treatment of viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  10. US 8936792

    Pseudomonas exotoxin a with reduced immunogenicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  11. US 8937067

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  12. US 8936787

    Peptides promoting lipid efflux

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  13. US 8933041

    System for treating and preventing breast cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  14. US 8927269

    Avian adenoassociated virus and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  15. US 8927725

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  16. US 8921097

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  17. US 8921340

    Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  18. US 8921323

    Methods and compositions for modulating BCL-2 family polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  19. US 8921050

    Methods of diagnosing renal cell carcinoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  20. US 8916175

    Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  21. US 8916570

    A3 adenosine receptor agonists and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  22. US 8916159

    Selenocysteine mediated hybrid antibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  23. US 8916596

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  24. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.